middle.news
BLIS Technologies Accelerates Growth with 16% Revenue Rise and IP Resolution
10:00am on Thursday 1st of January, 1970 AEST
•
Healthcare
Read Story
BLIS Technologies Accelerates Growth with 16% Revenue Rise and IP Resolution
10:00am on Thursday 1st of January, 1970 AEST
Key Points
16% revenue growth to $14.7 million in FY26
Underlying EBITDA rises to $1.8 million after supply chain cost adjustment
Intellectual property dispute with Bluestone Pharma resolved with joint patent ownership
Expanded Probi AB licence includes new territories and pet nutrition
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blis Technologies (NZX:BLT)
OPEN ARTICLE